Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

NCT07242612 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Osteoporosis, Postmenopausal

Interventions

DRUG: Alendronate, Ibandronate; Risedronate
DRUG: Teriparatide

Sponsor

Khyber Medical University Peshawar